Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from China Isotope & Radiation Corp. ( (HK:1763) ) is now available.
China Isotope & Radiation Corporation announced the successful results of its Extraordinary General Meeting (EGM) held on October 17, 2025. Key resolutions approved included the appointment of a domestic auditor for 2025 and the declaration of an interim dividend of RMB0.0807 per share for the first half of 2025. This decision reflects the company’s commitment to shareholder returns and may enhance its market positioning by demonstrating financial stability and operational transparency.
The most recent analyst rating on (HK:1763) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Isotope & Radiation Corp. stock, see the HK:1763 Stock Forecast page.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates within the nuclear technology industry, focusing on the production and distribution of isotopes and radiation-related products. The company is primarily engaged in providing services and products for medical, industrial, and scientific applications, with a significant market presence in China.
Average Trading Volume: 297,498
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.13B
Find detailed analytics on 1763 stock on TipRanks’ Stock Analysis page.